Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new patient-reported post-hoc data from the KINECT®-HD study highlighting significant reductions in both cognitive and motor-related ...

Chorea can affect various body parts and interfere with motor coordination, gait, swallowing and speech. HD is estimated to affect approximately 41,000 adults in the U.S., ...

Robeco Institutional Asset Management B.V. increased its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – ...

Background A 75-year-old woman with rheumatoid arthritis presented with a 4-year history of chorea to a hospital movement disorder clinic. The involuntary movements were initially mild, affecting ...

Explore the most effective treatments for Tourette syndrome, including behavioral therapy, medications, and advanced care ...

The chorea subsided slowly during and after the administration of chlorpromazine. The patient was discharged in May, 1955, and has since been followed in this clinic.

The Huntington disease Digital Motor Score, derived from smartphone sensor-based motor tests, can improve detection of disease progression.

Bessemer Group Inc. trimmed its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 67.3% in ...

Chorea: Involuntary, irregular, and abrupt movements that are a hallmark of certain neurological disorders. NKX2-1: A gene encoding the thyroid transcription factor-1, crucial for the development ...

Stanley Druckenmiller made a fortune working alongside billionaire George Soros. Today, Druckenmiller has a net worth of $6.9 ...

Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases, is ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Lewis Choi as Chief Information Officer, effective June 9, 2025.